Jan 27, 2025

Biomica’s Investor Meeting & Workshop

Biomica was delighted to host an inspiring investor meeting and workshop in Hong Kong, bringing together leading academics, local investors, researchers, and partners.
Dr. Elran Haber, Biomica’s CEO, presented the company’s cutting-edge advancements in microbiome-based therapeutics, while Prof. Gal Markel shared his insights into the recent positive Ph1 results and the transformative potential of these therapies in oncology. Dr. Jing Bao, Partner at @SHC and Biomica Board Member, along with Mr. Ofer Haviv, CEO of Evogene and Chairman of Biomica, also attended the event, expressing their confidence in Biomica’s promising initiatives.
We trust the discussions provided valuable insights into the opportunities within this rapidly evolving field and look forward to cultivating future collaborations.
A special thanks to Tehila Levi-Lati, for supporting this event and a wonderful hospitality!

Back to all News

Highlighted News About Biomica

Jan 27, 2025

2025 J.P. Morgan Annual Healthcare week

Dr. Elran Haber, CEO of Biomica will be attending Biotech Showcase 2025 as part of the J.P. Morgan Annual Healthcare week in San Francisco. If you’d like to meet with Dr. Haber, please get in touch through the partnering platform or DM us.

Jan 27, 2025

Microbiome Connect USA

Biomica’s CEO, Dr. Elran Haber, will be a featured panelist at the Microbiome Connect USA event on Wednesday, November 20, at 9:30 AM (local time). Join him for the session: “Taking the Bird’s Eye View: Market Insights & Dynamics of Microbiome Drug Development”.